Elsevier

Gastrointestinal Endoscopy

Volume 74, Issue 3, September 2011, Pages 593-602
Gastrointestinal Endoscopy

Original article
Clinical endoscopy
Randomized, controlled trial of standard-definition white-light, high-definition white-light, and narrow-band imaging colonoscopy for the detection of colon polyps and prediction of polyp histology

Presented at Digestive Disease Week, May 1-4, 2010, New Orleans, Louisiana (Gastrointest Endosc 2010;71:AB142).
https://doi.org/10.1016/j.gie.2011.04.050Get rights and content

Background

Missing adenomas and the inability to accurately differentiate between polyp histology remain the main limitations of standard-definition white-light (SD-WL) colonoscopy.

Objective

To compare the adenoma detection rates of SD-WL with those of high-definition white-light (HD-WL) and narrow-band imaging (NBI) as well as the accuracy of predicting polyp histology.

Design

Multicenter, prospective, randomized, controlled trial.

Setting

Two academic medical centers in the United States.

Patients

Subjects undergoing screening or surveillance colonoscopy.

Intervention

Subjects were randomized to undergo colonoscopy with one of the following: SD-WL, HD-WL, or NBI.

Main Outcome Measurements

The proportion of subjects detected with adenomas, adenomas detected per subject, and the accuracy of predicting polyp histology real time.

Results

A total of 630 subjects were included. The proportion of subjects with adenomas was 38.6% with SD-WL compared with 45.7% with HD-WL and 46.2% with NBI (P = .17 and P = .14, respectively). Adenomas detected per subject were 0.69 with SD-WL compared with 1.12 with HD-WL and 1.13 with NBI (P = .016 and P = .014, respectively). HD-WL and NBI detected more subjects with flat and right-sided adenomas compared with SD-WL (all P values <.005). NBI had a superior sensitivity (90%) and accuracy (82%) to predict adenomas compared with SD-WL and HD-WL (all P values <.005).

Limitations

Academic medical centers with experienced endoscopists.

Conclusions

There was no difference in the proportion of subjects with adenomas detected with SD-WL, HD-WL, and NBI. However, HD-WL and NBI detected significantly more adenomas per subject (>60%) compared with SD-WL. NBI had the highest accuracy in predicting adenomas in real time during colonoscopy. (Clinical Trial registration number: NCT 00614770.)

Section snippets

Study design

This was a multicenter prospective, randomized, controlled trial that was conducted at 2 tertiary referral centers. The study was approved by the local institutional review board at both centers and registered with Clinical Trials.gov (NCT 00614770).

Study population

Subjects referred and scheduled for screening or surveillance colonoscopy were prospectively enrolled between August 2008 and November 2009. Written informed consent was obtained from all subjects. Inclusion criteria were referral for screening or

Subjects

A total of 664 subjects were enrolled in the study between August 2008 and November 2009. Thirty-four subjects (5%) were excluded (Fig. 2): 5% in the SD-WL arm, 3% in HD-WL arm, and 7% in the NBI arm. Thus, a total of 630 subjects completed the study protocol, and these were included in the analysis: 210 in each study group. Table 1 shows the demographics of the subjects, indication for colonoscopy, insertion time, and withdrawal time. The mean age of subjects was statistically higher in the

Discussion

We report the results of a randomized, controlled trial comparing 3 commercially available imaging modalities (SD-WL, HD-WL, and NBI) for the detection of adenomas and prediction of polyp histology. This is the first trial to do so, all under the purview of 1 study. There was no significant difference in the proportion of subjects with adenomas (primary outcome) among SD-WL, HD-WL, and NBI. Both HD-WL and NBI detected a 7% higher proportion of subjects with adenomas compared with SD-WL, a

References (33)

Cited by (136)

  • Computer-aided detection versus advanced imaging for detection of colorectal neoplasia: a systematic review and network meta-analysis

    2021, The Lancet Gastroenterology and Hepatology
    Citation Excerpt :

    However, these trials were included in the supplementary subanalysis investigating the individual role of each technique in increasing the adenoma detection rate (appendix pp 19–23). Thus, 50 trials involving 34 445 participants were included in our main analysis.7,25–73 Ten studies were from the USA (5799 patients),25–34 eight from China (6747 patients),35–43 six from Germany (4183 patients),44–49 five from Italy (2440 patients),7,50–53 four from Japan (2315 patients),54–57 two from South Korea (728 patients),58,59 two from Australia (1326 patients),60,61 two from the Netherlands (2402 patients),62,63 three from the UK (745 patients),64–66 and one study each from Belgium (1065 patients),67 Brazil (541 patients),68 Israel (1000 patients),69 Mexico (337 patients),70 Romania (505 patients),71 Spain (238 patients),72 and France (2058 patients).73

  • How to Approach Small Polyps in Colon: Tips and Tricks

    2021, Techniques and Innovations in Gastrointestinal Endoscopy
  • High-definition colonoscopy for improving adenoma detection: a systematic review and meta-analysis of randomized controlled studies

    2020, Gastrointestinal Endoscopy
    Citation Excerpt :

    Participants’ gender (male, 45.7% vs 68%) and mean age (58.2 vs 62.5 years) were similar, and there were no significant differences in the bowel preparation quality between the 2 arms among the studies that reported on this outcome.11,13-15 No difference in withdrawal times—assessed in 4 studies11-13,16 with 2517 participants—was noted between the HD-WLE and SDC groups (MD, −0.06; 95% CI, −0.25 to 0.12; P = .50; I2 = 0%; P = .44). Histopathologic samples were analyzed according to the Vienna classification17,18 in 2 studies,14,15 World Health Organization classification19 in one study16; the other 3 studies11-13 did not provide relevant details.

View all citing articles on Scopus

Dr Rastogi was supported by a research grant from Olympus America Inc.

DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: Dr Rastogi: research grant from Olympus America Inc; Dr Edmundowicz: consultant to, honorarium from, and member of the advisory board of Olympus America Inc; Dr Sharma: grant support from Olympus America Inc. The other authors disclosed no financial relationships relevant to this publication. Dr Rastogi is the recipient of the Michael V. Sivak Jr. MD Endoscopic Research Award from the American Society for Gastrointestinal Endoscopy.

See CME section; p. 634.

If you would like to chat with an author of this article, you may contact Dr. Rastogi at [email protected].

View full text